ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this animation:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

Working with XVIVO on the Giant Heart for the Museum of Science and Industry has been an absolute delight. The final result in the space of the museum is really a knockout. Thanks for an exemplary job.

Tom Hennes, Principal, Thinc Design
Share this animation: